Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
248.00    3.00 (1.22%)
Bid:
249.00
Ask:
250.00
Spread: 1.00 (0.402%)
Market Cap: £144.67m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

AGM Statement

5 Dec 2019 07:00

RNS Number : 7186V
MJ Gleeson PLC
05 December 2019
 

MJ Gleeson plc

(GLE.L)

 

AGM Statement

 

MJ Gleeson plc (GLE.L), the low-cost housebuilder and strategic land specialist, will today hold its Annual General Meeting in Sheffield. Dermot Gleeson, Chairman, will make the following comments:

"Demand at Gleeson Homes is strong with net reservations since the start of the current financial year to 30 June 2020 ("FY2020") up more than 10% compared with the same period last year.

"Land continues to be available at sensible prices and the pipeline remains strong. Gleeson Homes has a pipeline of 13,042 plots with a gross development value of £1.7 billion, of which 6,910 plots are owned and 6,132 are conditionally purchased.

"The division currently has 64 active sites, compared with 62 at this time last year, but expects to open significantly more sites in the second half of FY2020.

"Strong demand, good mortgage availability and our ability to offer attractive levels of affordability to our customers, means the outlook for the division remains very positive.

 

"The Board expects Gleeson Homes to record an increase in completions for the half year to 31 December 2019 of approximately 10% compared with the prior half year total of 691 units; and an increase in completions for FY2020 of at least 10% compared with the prior year total of 1,529 units.

"Gleeson Strategic Land continues to experience strong demand for consented land. The majority of the division's land sales are expected in the second half of FY2020. Accordingly, and in line with our expectations, results for the first half are expected to be lower than the unusually high results for the first half last year.

"The division's land pipeline currently consists of 64 sites which have the potential to deliver approximately 22,175 plots. The portfolio includes 10 sites which now have planning permission.

"Against this background the Board remains confident that the Group's results for FY2020 will be in line with expectations.

"We announced in September the appointment of Andrew Coppel and Fiona Goldsmith to the Board as non-executive Directors with effect from 1st October 2019. Colin Dearlove, Senior Independent Director and Ross Ancell, Non-Executive Director will be stepping down from the Board in June 2020. The Board would like to thank both Colin and Ross for the invaluable guidance and support they have provided over the years."

 

5 December 2019

 

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of the company is Stefan Allanson, Chief Financial Officer.

 

LEI: 21380064K7N2W7FD6434

 

Enquiries:

MJ Gleeson plc

Tel: +44 1142 612900

James Thomson

Chief Executive Officer

Stefan Allanson

Chief Financial Officer

Instinctif Partners

Tel: +44 20 7457 2020

Mark Garraway

James Gray

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

Rachel Hayes

Liberum

Neil Patel

Tel: +44 20 3100 2222

Richard Bootle

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMKMMGZVDGGLZM
Date   Source Headline
20th Feb 20189:37 amRNSHolding(s) in Company
19th Feb 20187:00 amRNSHalf-year Report
7th Feb 20184:40 pmRNSSecond Price Monitoring Extn
7th Feb 20184:35 pmRNSPrice Monitoring Extension
7th Feb 20182:21 pmRNSDirector/PDMR Shareholding
31st Jan 20187:00 amRNSTotal Voting Rights
10th Jan 20182:10 pmRNSDirector/PDMR Shareholding
4th Jan 20187:00 amRNSTrading Update
29th Dec 20177:00 amRNSTotal Voting Rights
8th Dec 201711:51 amRNSDirector/PDMR Shareholding
8th Dec 20178:53 amRNSDirector/PDMR Shareholding
7th Dec 20174:26 pmRNSResult of AGM
7th Dec 20177:00 amRNSAGM Statement
30th Nov 20177:00 amRNSTotal Voting Rights
23rd Nov 20175:48 pmRNSDirector/PDMR Shareholding
23rd Nov 20175:44 pmRNSHolding(s) in Company
8th Nov 20174:54 pmRNSDirector/PDMR Shareholding
8th Nov 20174:43 pmRNSHolding(s) in Company
8th Nov 20174:25 pmRNSDirector/PDMR Shareholding
6th Nov 20177:00 amRNSNotice of AGM
31st Oct 20177:00 amRNSTotal Voting Rights
6th Oct 20172:07 pmRNSDirector/PDMR Shareholding
4th Oct 201711:31 amRNSExercise of Options, TVR & Director/PDMR Dealings
29th Sep 20177:00 amRNSTotal Voting Rights
26th Sep 20174:06 pmRNSPerformance Share Plan Award to Directors
25th Sep 20177:00 amRNSFinal Results
8th Sep 20174:35 pmRNSPrice Monitoring Extension
7th Sep 20179:59 amRNSDirector/PDMR Shareholding
31st Aug 20177:00 amRNSTotal Voting Rights
23rd Aug 201712:07 pmRNSSecond Price Monitoring Extn
23rd Aug 201712:02 pmRNSPrice Monitoring Extension
22nd Aug 20174:35 pmRNSPrice Monitoring Extension
9th Aug 20179:13 amRNSDirector/PDMR Shareholding
31st Jul 20177:00 amRNSTotal Voting Rights
18th Jul 20174:55 pmRNSDirector/PDMR Shareholding
7th Jul 201710:06 amRNSDirector/PDMR Shareholding
5th Jul 20177:00 amRNSTrading Update
30th Jun 20177:00 amRNSTotal Voting Rights
6th Jun 20175:17 pmRNSDirector/PDMR Shareholding
31st May 20177:00 amRNSTotal Voting Rights
25th May 20171:27 pmRNSDirector/PDMR Shareholding
11th May 20171:11 pmRNSDirector/PDMR Shareholding
28th Apr 20177:00 amRNSTotal Voting Rights
24th Apr 20178:49 amRNSHolding(s) in Company
6th Apr 20176:11 pmRNSDirector/PDMR Shareholding
31st Mar 20177:00 amRNSTotal Voting Rights
7th Mar 20175:10 pmRNSDirector/PDMR Shareholding
3rd Mar 20176:14 pmRNSHolding(s) in Company
28th Feb 20177:00 amRNSTotal Voting Rights
27th Feb 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.